Leuven, Belgium

Jean-Christophe Vanherck

USPTO Granted Patents = 2 

Average Co-Inventor Count = 8.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jean-Christophe Vanherck

Introduction

Jean-Christophe Vanherck is a notable inventor based in Leuven, Belgium. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating specific disorders. With a total of 2 patents, his work focuses on innovative solutions for health-related challenges.

Latest Patents

Jean-Christophe Vanherck's latest patents include the invention of heterocycle derivatives for treating TRPM3 mediated disorders. This invention relates to compounds that are useful for the prevention or treatment of TRPM3 mediated disorders, specifically targeting conditions such as pain and inflammatory hypersensitivity. The invention also encompasses a method for the prevention or treatment of these disorders, showcasing his commitment to advancing medical science.

Career Highlights

He is affiliated with Katholieke Universiteit Leuven, where he engages in research and development activities. His work at the university allows him to collaborate with other experts in the field, further enhancing the impact of his inventions.

Collaborations

One of his notable collaborators is Patrick Chaltin, with whom he has worked on various projects aimed at improving therapeutic options for patients.

Conclusion

Jean-Christophe Vanherck's contributions to the field of medicinal chemistry through his patents and collaborations highlight his dedication to innovation in healthcare. His work continues to pave the way for new treatments that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…